Future FinTech Group Acquires TransGen to Enter Biomedical Innovation Sector

Future FinTech Expands into Biomedical Innovation with TransGen Acquisition

Future FinTech Group, a leader in financial and digital technology services, takes a significant step into the biomedical field by signing a Framework Agreement to acquire 100% of TransGen SC Tech Limited through its subsidiary, Future FinTech (Hong Kong) Limited. This strategic move, announced on January 7, 2026, aims to enhance Future FinTech's health and wellness portfolio by integrating TransGen’s cutting-edge research and development in biofactors. The acquisition process is set to be completed within 90 calendar days, contingent upon the successful completion of due diligence and a financial audit, paving the way for a formal acquisition agreement if the results meet expectations.

TransGen is recognized for its pioneering work in creating innovative treatments for diabetes and Alzheimer’s disease. The company’s research primarily focuses on exploring the potential of microalgal extracellular vesicles, which are envisioned as nanocarriers for drug delivery and diagnostics. Holding 26 invention and utility model patents, TransGen showcases its dedication to advancing biomedical science. Additionally, the company has established itself as a leader in the industry by contributing to the development of standards for stem cell processing and maintaining certifications such as the Level 2 Biosafety Laboratory Certification and the Human Umbilical Cord Mesenchymal Stem Cells Qualification Certificate, ensuring compliance with rigorous health and safety regulations.

Gai Wei, Director of TransGen, expresses enthusiasm about the partnership with Future FinTech, citing the potential for enhanced international expansion driven by the collaboration. By leveraging Future FinTech’s extensive global resources, TransGen aims to amplify its technological capabilities and broaden its market reach. This acquisition aligns with Future FinTech's mission of integrating advanced technology solutions across various sectors, signaling a commitment to innovation in the health and wellness industry. As the companies move forward, they expect to drive significant advancements in biomedical technologies that could transform treatment options for chronic diseases.

In addition to the acquisition, Future FinTech positions itself strategically within the evolving landscape of health technology, where the fusion of financial resources and cutting-edge biomedical research can lead to unprecedented breakthroughs. As the healthcare sector increasingly embraces innovation, this partnership could play a pivotal role in addressing critical health challenges. The collaboration not only enhances Future FinTech's service offerings but also underscores its dedication to improving global health through technology-driven solutions.